Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2011-08-30
2011-08-30
Goddard, Laura B (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S007100, C435S007230
Reexamination Certificate
active
08008004
ABSTRACT:
The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumors of glial origin in mammals and to methods of using those compositions of matter for the same.
REFERENCES:
patent: 6416758 (2002-07-01), Thorpe et al.
patent: 6428788 (2002-08-01), Debinski et al.
patent: 6518061 (2003-02-01), Puri et al.
patent: 2003/0082586 (2003-05-01), Kirst et al.
patent: 2000-511042 (2000-08-01), None
patent: 96/29417 (1996-09-01), None
patent: 00/35935 (2000-06-01), None
patent: WO 01/36685 (2001-05-01), None
patent: 03/024392 (2003-03-01), None
Valasek and Repa (Adv. Physiolo. Educ. 2005; 29: 151-159).
Bustin and Nolan (Journal of Biomolecular Techiques 2004; 15: 155-166).
Bustin (Journal of Molecular Endocrinology 2002; 29: 23-29).
Li at al., “Targeting glioblastoma multiforme with an IL-13/diphtheria toxin fusion protein in vitro and in vivo in nude mice”Protein Engineering15:419-427 (2002).
M. Dorvillius, et al., “Targeting of human breast cancer by a bispecific antibody directed against two tumor-associated antigens: ErbB-2 and carcinoembryonic antigen”Tumor Biology23:337-347 (2002).
R. W. Weller, “Chemotherapy and Immunotherapy of malignant glioma: molecular mechanisms and clinical perspectives”Cell Mol Life Sci. 56:481-506 (Oct. 30, 1999).
Roth et al., “(abstact only)”Cell Mol. Life Sci. 56(5-6):481-506 (1999).
S. Gunia, et al., “CD44s-targeted treatment with monoclonal antibody blocks intracerebral invasion and growth at 9L gliosarcoma”Clinical&Experimental Metastasis17:221-230 (1999).
S. M. Kipriyanov, et al., “Generation of Recombinant Antibodies”Molecular Biotechnology12:173-201 (1999).
Samoylova et al., “Molecular Markers of Glial Tumors: Current Targeting Strategies”Current Medicinal Chemistry10:831-843 (2003).
Raggi, C.C. et al., “Quantitative evaluation of somatostatin receptor subtype 2 expression in sporadic colorectal tumor and in the corresponding normal mucosa”Clin. Cancer Res. 8:419-427 (Feb. 2002).
Rich J N et al, “Gene Expression profiling and genetic markers in glioblastoma survival”Cancer Research, American Association for Cancer Research, Baltimore, MD, US 65(10):4051-4058 (May 15, 2005).
Salonga, D.S. et al., “Relative gene expression in normal and tumor tissue by quantitative RT-PCR”Meth. Mol. Biol. 191:83-98 (Mar. 1, 2002).
Zhou Yi-Hong et al., “Modeling prognosis for patients with malignant astrocytic gliomas: quantifying the expression of multiple genetic markers and clinical variables”Neuro-Oncology7(4):485-494 (Oct. 2005).
Sahasrabudhe et al., “Enzymatic Biological Chemistry 268(22):16699-16705 generation of the amino terminus of the beta-amyloid peptide” (Aug. 5, 1993)Journal of biological Chemistry268(22): 16699-16705 (Aug. 5, 1993).
Fang Carol A.
Genentech Inc.
Goddard Laura B
LandOfFree
Compositions and methods for the diagnosis and treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for the diagnosis and treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for the diagnosis and treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2656473